Published in
Springer Verlag, PharmacoEconomics, 6(35), p. 665-667
DOI: 10.1007/s40273-017-0507-3
Links
Tools
Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”
Journal article published in 2017 by
Bram L. T. Ramaekers 
,
Rob Riemsma,
Florian Tomini,
Thea van Asselt,
Sohan Deshpande,
Steven Duffy,
Nigel Armstrong,
Johan L. Severens,
Jos Kleijnen,
Manuela A. Joore
,
Rob Riemsma,
Florian Tomini,
Thea van Asselt,
Sohan Deshpande,
Steven Duffy,
Nigel Armstrong,
Johan L. Severens,
Jos Kleijnen,
Manuela A. Joore
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 